Abstract
Background
There is a paucity of research concerning cognitive impairments in Inflammatory bowel disease - ulcerative colitis (IBD-UC) and irritable bowel syndrome (IBS). Studies on cognitive dysfunction in patients with IBD-UC have either been small or have shown conflicting results. This study is conducted to examine the evidence of cognitive dysfunction in IBD-UC patients in remission and compare the evident cognitive deficit with IBS patients and healthy controls.
Methods
This single-centre cross-sectional observational study enrolled a total of 90 participants, 29 in ulcerative colitis (UC) in remission group, 31 in IBS group and 30 in healthy control group. Assessment of cognition with the help of cognitive function tests mini-mental state examination (MMSE), Montreal Cognitive Assessment (MoCA) test and p300 was performed in all participants.
Results
A statistically significant number of the participants in IBD-UC in remission group had MMSE and MoCA score below the lower limit of normal, in comparison to the healthy control and IBS groups. The mean peak latency of the p300 wave was statistically significantly increased in people in the IBD-UC group, in comparison to the healthy control and IBS groups.
Conclusion
Patients with IBD-UC in remission show impairments in cognitive functioning compared to the IBS and healthy control groups as assessed on cognitive function testing on MMSE, MoCA and mean peak latency of the p300 wave. This impairment in cognitive function is unlikely to be due to premorbid levels of intellectual functioning and is likely to have impact on health-related quality of life.
Similar content being viewed by others
References
Thompson WG. The irritable gut. The inside tract. 2001;126:10–11.
Lechin F, van der Dijs B, Lechin ME. Plasma neurotransmitters and functional illness. Psychother Psychosom. 1996;65:293–318.
Casella G, Tontini GE, Bassotti G, et al. Neurological disorders and inflammatory bowel diseases. World J Gastroenterol. 2014;20:8764–82.
Gareau M. Cognitive function and the microbiome. Int Rev Neurobiol. 2016;131:227–46.
Attree E, Dancey C, Keeling D, Wilson C. Cognitive function in people with chronic illness: inflammatory bowel disease and irritable bowel syndrome. Appl Neuropsychol Adult. 2003;10:96–104.
Dancey CP, Attree EA, Stuart G, Wilson C, Sonnet A. Words fail me: the verbal IQ deficit in inflammatory bowel disease and irritable bowel syndrome. Inflamm Bowel Dis. 2009;15:852–7.
Golan D, Gross B, Miller A, et al. Cognitive function of patients with Crohn’s disease is associated with intestinal disease activity. Inflamm Bowel Dis. 2019;22:364–71.
van Langenberg D, Yelland G, Robinson S, Gibson PR. Cognitive impairment in Crohn’s disease is associated with systemic inflammation, symptom burden and sleep disturbance. United European Gastroenterol J. 2017;5:579–87.
Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20:91–9.
Mrakotsky C, Forbes PW, Bernstein JH, et al. Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease. J Int Neuropsychol Soc. 2013;19:96–109.
Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis. 2011;17:1564–72.
Smith PJ, Blumenthal JA. Dietary factors and cognitive decline. J Prev Alzheimers Dis. 2016;3:53–64.
Wells C, Lewis S, Barton R, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12:123–30.
Han SW, McColl E, Barton JR, James P, Steen IN, Welfare MR. Predictors of quality of life in ulcerative colitis: the importance of symptoms and illness representations. Inflamm Bowel Dis. 2005;11:24–34.
Fan W, Zhang S, Hu J, et al. Aberrant brain function in active-stage ulcerative colitis patients: a resting-state functional MRI study. Front Hum Neurosci. 2019;13:107.
Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016:S0016-5085(16)00222-5.
Blomhoff S, Spetalen S, Jacobsen MB, Malt UF. Phobic anxiety changes the function of the brain-gut axis in irritable brain syndrome. Psychosom Med. 2001;63:959–65.
Marshall PS, Forstot M, Callies A, Peterson PK, Schenck CH. Cognitive slowing and working memory difficulties in chronic fatigue syndrome. Psychosom Med. 1997;59:58–66.
Brosschot JF, Thayer JF. Worry, perseverative thinking, and health. In: Temoshok LR, editor. Biobehavioral Perspectives on Health and Disease, 6. Harwood Academic Publishers; 2004.
Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the non-invasive components of the mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660–6.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Mungas D. In-office mental status testing: a practical guide. Geriatrics. 1991;46:54–8, 63, 66.
Nys GM, van Zandvoort MJ, de Kort PL, Jansen BP, Kappelle LJ, de Haan EH. Restrictions of the mini-mental state examination in acute stroke. Arch Clin Neuropsychol. 2005;20:623–9.
Dey J, Misra A, Desai NG, Mahapatra AK, Padma MV. Cognitive function in younger type II diabetes. Diabetes Care. 1997;20:32–5.
Komulainen P, Lakka TA, Kivipelto M. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement Geriatr Cogn Disord. 2007;23:29–34.
Nasreddine ZS, Collin I, Chertkow H, et al. Sensitivity and specificity of the Montreal Cognitive Assessment (MoCA) for detection of mild cognitive deficits. Can J Neurol Sci. 2003;30:30.
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry. 2007;52:329–32.
Polich J, Howard L, Starr A. P300 latency correlated with digit span. Psychophysiology. 1983;20:665–9.
Berrill JW, Gallacher J, Hood K, et al. An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease. Neurogastroenterol Motil. 2013;25:e918–704.
Kennedy PJ, Clarke G, Quigley EM, Groeger JA, Dinan TG, Cryan JF. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev. 2012;36:310–40.
Farup PG, Hestad K. Cognitive functions and depression in patients with irritable bowel syndrome. Gastroenterol Res Pract. 2015;438329:9.
Hollerbach S, Kullman F, Geissler A, et al. Impairment of short-term memory function and morphologic brain abnormalities in inflammatory bowel disease. Gastroenterology. 2000;118:1723.
Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part I. Inflamm Bowel Dis. 2018;24:742–51.
Gracie DJ, Irvine AJ, Sood R, Mikocka-Walus A, Hamlin PJ, Ford AC. Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:189–99.
Funding
None.
Author information
Authors and Affiliations
Contributions
Study concept and protocol design: Neetu Sharma, Sanjay Dhiman, Vishal Bodh, Deepak Sharma, Rajesh Sharma, Sudhir Sharma, Brij Sharma. Collecting data: Neetu Sharma, Sanjay Dhiman, Vishal Bodh, Rajesh Sharma. Analysis of data: Deepak Sharma. Preparing the initial draft of the manuscript: Neetu Sharma, Sanjay Dhiman, Vishal Bodh, Rajesh Sharma. Critical revision of the manuscript for intellectual content: Neetu Sharma, Vishal Bodh, Rajesh Sharma. Obtained funding: None. Administrative, technical or material support: Neetu Sharma, Sanjay Dhiman, Vishal Bodh, Rajesh Sharma, Sudhir Sharma, Brij Sharma. Study supervision: Brij Sharma, Vishal Bodh, Rajesh Sharma.
Corresponding author
Ethics declarations
Conflict of interest
NS, SD, VB, DS, RS, SS,and BS declare that they have no conflict of interest.
Ethics statement
The authors declare that the study was performed in a manner conforming to the Helsinki declaration of 1975 as revised in 2000 and 2008 concerning human and animal rights and the authors followed the policy concerning informed consent as shown on Springer.com.
Disclaimer
The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Department of Physiology, Indira Gandhi Medical College, Shimla Himachal Pradesh
Rights and permissions
About this article
Cite this article
Sharma, N., Dhiman, S., Bodh, V. et al. Cognitive dysfunction in ulcerative colitis patients in remission and its comparison with patients with irritable bowel syndrome and healthy controls. Indian J Gastroenterol 40, 169–175 (2021). https://doi.org/10.1007/s12664-020-01122-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-020-01122-y